PAX6, a novel target of miR-335, inhibits cell proliferation and invasion in glioma cells Retraction in /10.3892/mmr.2021.12299

Cheng,Quan; Cao,Hui; Chen,Zigui; Ma,Zhiming; Wan,Xin; Peng,Renjun; Jiang,Bing

doi:10.3892/mmr.2014.2150

PAX6, a novel target of miR-335, inhibits cell proliferation and invasion in glioma cells

Retraction in: /10.3892/mmr.2021.12299

Authors:
- Quan Cheng
- Hui Cao
- Zigui Chen
- Zhiming Ma
- Xin Wan
- Renjun Peng
- Bing Jiang
View Affiliations

Affiliations: Department of Neurosurgery, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China, Department of Neurosurgery, Brain Hospital of Hunan Province, The Affiliated Hospital of Hunan Traditional Chinese Medicine University, Changsha, Hunan 410007, P.R. China
Published online on: April 15, 2014 https://doi.org/10.3892/mmr.2014.2150
Pages: 399-404

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Paired box 6 (PAX6), a highly conserved transcription factor, is important in glioma. However, the molecular mechanisms involved remain unclear. The present study demonstrated that the expression of PAX6 was significantly reduced with the malignancy of glioma and also identified PAX6 as a novel target of microRNA (miR)‑335, which was significantly upregulated in glioma. The inhibition of miR‑335 increased the protein expression of PAX6, whereas the upregulation of miR‑335 suppressed its expression in human glioma U251 and U87 cells. Furthermore, upregulation of miR-335 promoted U251 cell proliferation, colony formation and invasion, which was reversed by the overexpression of PAX6. Furthermore, the present study demonstrated that the effect of miR‑335 on U251 cell invasion was via the modulation of matrix metalloproteinase (MMP)‑2 and MMP‑9 expression by targeting PAX6. In conclusion, the present study demonstrated that PAX6, as a novel target of miR‑335, has an anti‑oncogenic function in glioma, and thus PAX6 may serve as a therapeutic target for glioma.

View Figures

View References

1	Shaham O, Menuchin Y, Farhy C and Ashery-Padan R: Pax6: a multi-level regulator of ocular development. Prog Retin Eye Res. 31:351–376. 2012. View Article : Google Scholar : PubMed/NCBI
2	Gosmain Y, Cheyssac C, Heddad Masson M, Dibner C and Philippe J: Glucagon gene expression in the endocrine pancreas: the role of the transcription factor Pax6 in alpha-cell differentiation, glucagon biosynthesis and secretion. Diabetes Obes Metab. 13(Suppl 1): 31–38. 2011. View Article : Google Scholar : PubMed/NCBI
3	Xie Q, Yang Y, Huang J, et al: Pax6 interactions with chromatin and identification of its novel direct target genes in lens and forebrain. PLoS One. 8:e545072013. View Article : Google Scholar : PubMed/NCBI
4	Mayes DA, Hu Y, Teng Y, et al: PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene. Cancer Res. 66:9809–9817. 2006. View Article : Google Scholar : PubMed/NCBI
5	Zhou YH, Tan F, Hess KR and Yung WK: The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival. Clin Cancer Res. 9:3369–3375. 2003.PubMed/NCBI
6	Stewart LA: Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet. 359:1011–1018. 2002. View Article : Google Scholar : PubMed/NCBI
7	Zhu VF, Yang J, Lebrun DG and Li M: Understanding the role of cytokines in Glioblastoma Multiforme pathogenesis. Cancer Lett. 316:139–150. 2012. View Article : Google Scholar : PubMed/NCBI
8	Sathornsumetee S, Reardon DA, Desjardins A, Quinn JA, Vredenburgh JJ and Rich JN: Molecularly targeted therapy for malignant glioma. Cancer. 110:13–24. 2007. View Article : Google Scholar : PubMed/NCBI
9	Pulkkanen KJ and Yla-Herttuala S: Gene therapy for malignant glioma: current clinical status. Mol Ther. 12:585–598. 2005. View Article : Google Scholar : PubMed/NCBI
10	Ambros V: The functions of animal microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
11	Nikaki A, Piperi C and Papavassiliou AG: Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy. Expert Opin Investig Drugs. 21:1475–1488. 2012. View Article : Google Scholar : PubMed/NCBI
12	Ling N, Gu J, Lei Z, et al: microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma. Oncol Rep. 30:2111–2118. 2013.PubMed/NCBI
13	Lin L, Chen X, Peng X, et al: MicroRNA-128 promotes cell-cell adhesion in U87 glioma cells via regulation of EphB2. Oncol Rep. 30:1239–48. 2013.PubMed/NCBI
14	Wang Y, Zhao W and Fu Q: miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells. Mol Cell Biochem. 384:105–11. 2013. View Article : Google Scholar : PubMed/NCBI
15	Gong M, Ma J, Guillemette R, et al: miR-335 inhibits small cell lung cancer bone metastases via IGF-1R and RANKL pathways. Mol Cancer Res. Aug 21–2013.(Epub ahead of print).
16	Walter BA, Valera VA, Pinto PA and Merino MJ: Comprehensive microRNA profiling of prostate cancer. J Cancer. 4:350–357. 2013. View Article : Google Scholar
17	Cao J, Cai J, Huang D, et al: miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w. Oncol Rep. 30:701–706. 2013.PubMed/NCBI
18	Xiong SW, Lin TX, Xu KW, et al: MicroRNA-335 acts as a candidate tumor suppressor in prostate cancer. Pathol Oncol Res. 19:529–537. 2013. View Article : Google Scholar : PubMed/NCBI
19	Liu J, Mao Q, Liu Y, Hao X, Zhang S and Zhang J: Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. Chin J Cancer Res. 25:46–54. 2013.PubMed/NCBI
20	Dohi O, Yasui K, Gen Y, et al: Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma. Int J Oncol. 42:411–418. 2013.PubMed/NCBI
21	Shi L, Jiang D, Sun G, et al: miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas. J Neurooncol. 110:155–162. 2012. View Article : Google Scholar : PubMed/NCBI
22	Yan Z, Xiong Y, Xu W, et al: Identification of hsa-miR-335 as a prognostic signature in gastric cancer. PLoS One. 7:e400372012. View Article : Google Scholar : PubMed/NCBI
23	Jiang J, Sun X, Wang W, et al: Tumor microRNA-335 expression is associated with poor prognosis in human glioma. Med Oncol. 29:3472–3477. 2012. View Article : Google Scholar : PubMed/NCBI
24	Yamaoka T and Itakura M: Development of pancreatic islets (review). Int J Mol Med. 3:247–261. 1999.
25	Liu RZ, Monckton EA and Godbout R: Regulation of the FABP7 gene by PAX6 in malignant glioma cells. Biochem Biophys Res Commun. 422:482–487. 2012. View Article : Google Scholar : PubMed/NCBI
26	Zhou YH, Wu X, Tan F, et al: PAX6 suppresses growth of human glioblastoma cells. J Neurooncol. 71:223–229. 2005. View Article : Google Scholar : PubMed/NCBI
27	Shu M, Zheng X, Wu S, et al: Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells. Mol Cancer. 10:592011. View Article : Google Scholar : PubMed/NCBI
28	Shu M, Zhou Y, Zhu W, et al: MicroRNA 335 is required for differentiation of malignant glioma cells induced by activation of cAMP/protein kinase A pathway. Mol Pharmacol. 81:292–298. 2012. View Article : Google Scholar : PubMed/NCBI
29	Kaspi H, Chapnik E, Levy M, Beck G, Hornstein E and Soen Y: Brief report: miR-290–295 regulate embryonic stem cell differentiation propensities by repressing Pax6. Stem Cells. 31:2266–2272. 2013.PubMed/NCBI
30	Wang J, Wang X, Wu G, Hou D and Hu Q: MiR-365b-3p, down-regulated in retinoblastoma, regulates cell cycle progression and apoptosis of human retinoblastoma cells by targeting PAX6. FEBS Lett. 587:1779–1786. 2013. View Article : Google Scholar : PubMed/NCBI
31	Chen KC, Hsi E, Hu CY, Chou WW, Liang CL and Juo SH: MicroRNA-328 may influence myopia development by mediating the PAX6 gene. Invest Ophthalmol Vis Sci. 53:2732–2739. 2012. View Article : Google Scholar : PubMed/NCBI
32	Huang BS, Luo QZ, Han Y, Li XB, Cao LJ and Wu LX: microRNA-223 promotes the growth and invasion of glioblastoma cells by targeting tumor suppressor PAX6. Oncol Rep. 30:2263–2269. 2013.PubMed/NCBI
33	Levicar N, Nuttall RK and Lah TT: Proteases in brain tumour progression. Acta Neurochir (Wien). 145:825–838. 2003. View Article : Google Scholar : PubMed/NCBI